Literature DB >> 24479738

Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication.

Anthony W H Chan1, Ronald C K Chan, Grace L H Wong, Vincent W S Wong, Paul C L Choi, Henry L Y Chan, Ka-Fai To.   

Abstract

AIMS: A new Japanese histological staging system for primary biliary cirrhosis (PBC) has been proposed. We aimed to evaluate the efficacies of the Scheuer, Ludwig and Japanese staging systems, with emphasis on their clinical and biochemical correlations and prognostic significances. METHODS AND
RESULTS: We conducted a retrospective review of a cohort of 58 Chinese PBC patients, with follow-up of up to 16.9 years. All three systems correlated well with prognostically significant parameters, namely serum bilirubin, Mayo scores and model for end-stage liver disease (MELD) score. Only the Japanese staging system was associated with Child-Pugh score, which was the single independent prognostic factor for liver-related events (log-rank P < 0.001; Cox proportional hazard ratio (HR) 6.723, P < 0.001). The Japanese system (log-rank P = 0.007; Cox proportional HR 10.400, P = 0.025) predicted liver-related events, while Scheuer (log-rank P = 0.112) and Ludwig (log-rank P = 0.147) systems did not. The copper-associated protein (CAP) deposition score, a component of the Japanese system, was the most powerful histological prognostic parameter (log-rank P < 0.001; Cox proportional HR 99.534, P = 0.049) and provided extra prognostic values in additional to serum albumin, serum bilirubin, Child-Pugh score, Mayo scores and MELD score.
CONCLUSION: The Japanese staging system is more effective than classical systems. The degree of CAP deposition is an essential prognostic histological parameter.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Child-Pugh score; Ludwig stage; MELD score; Mayo risk score; Scheuer stage; copper-associated protein

Mesh:

Year:  2014        PMID: 24479738     DOI: 10.1111/his.12384

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

2.  Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.

Authors:  Ana Lleo; Zhaolian Bian; Haiyan Zhang; Qi Miao; Fang Yang; Yanshen Peng; Xiaoyu Chen; Ruqi Tang; Qixia Wang; Dekai Qiu; Jingyuan Fang; Cristina Sobacchi; Anna Villa; Luca Di Tommaso; Massimo Roncalli; M Eric Gershwin; Xiong Ma; Pietro Invernizzi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

3.  Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study.

Authors:  Xiaoli Fan; Yongjun Zhu; Ruoting Men; Maoyao Wen; Yi Shen; Changli Lu; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-02

4.  Erythrocyte count is associated with prognosis in Chinese patients with primary biliary cholangitis.

Authors:  Yinghao Chang; Changcun Guo; Guanya Guo; Zhou Yuan; Xinmin Zhou; Jingbo Wang; Zheyi Han; Yu Chen; Gui Jia; Ying Han
Journal:  Exp Ther Med       Date:  2020-01-13       Impact factor: 2.447

5.  Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis.

Authors:  Mustafa Tahtaci; Oyku T Yurekli; Aylin D Bolat; Serdar Balci; Fatma E Akin; Naciye S Buyukasik; Osman Ersoy
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-12       Impact factor: 2.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.